Literature DB >> 22824948

AME position statement: primary hyperparathyroidism in clinical practice.

Michele Zini1, Roberto Attanasio, Roberto Cesareo, Ignazio Emmolo, Andrea Frasoldati, Laura Gianotti, Rinaldo Guglielmi, Alessandro Piovesan, Massimo Procopio, Alfredo Scillitani, Annibale Versari, Jens Bollerslev, Dhanwada Sudhaker Rao, Claudio Marcocci, Giorgio Borretta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22824948

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  11 in total

1.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

2.  Subclinical urolithiasis in patients with asymptomatic primary hyperparathyroidism.

Authors:  Hussam Abusahmin; John Geen; Gautam Das
Journal:  Ther Adv Endocrinol Metab       Date:  2018-07-24       Impact factor: 3.565

3.  Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).

Authors:  L Rosato; M Raffaelli; R Bellantone; A Pontecorvi; N Avenia; M Boniardi; M L Brandi; F Cetani; M G Chiofalo; G Conzo; M De Palma; G Gasparri; A Giordano; N Innaro; E Leopaldi; G Mariani; C Marcocci; P Marini; P Miccoli; P Nasi; F Pacini; R Paragliola; M R Pelizzo; M Testini; G De Toma
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

4.  Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Authors:  F Saponaro; F Cetani; A Repaci; U Pagotto; C Cipriani; J Pepe; S Minisola; C Cipri; F Vescini; A Scillitani; A Salcuni; S Palmieri; C Eller-Vainicher; I Chiodini; B Madeo; E Kara; E Castellano; G Borretta; L Gianotti; F Romanelli; V Camozzi; A Faggiano; S Corbetta; L Cianferotti; M L Brandi; M L De Feo; A Palermo; G Vezzoli; F Maino; M Scalese; C Marcocci
Journal:  J Endocrinol Invest       Date:  2018-04-03       Impact factor: 4.256

Review 5.  MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

Authors:  Jens Bollerslev; Camilla Schalin-Jäntti; Lars Rejnmark; Heide Siggelkow; Hans Morreau; Rajesh Thakker; Antonio Sitges-Serra; Filomena Cetani; Claudio Marcocci
Journal:  Eur J Endocrinol       Date:  2019-06-01       Impact factor: 6.664

6.  Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.

Authors:  Ying Wei; Lili Peng; Yan Li; Zhen Long Zhao; Ming An Yu
Journal:  Korean J Radiol       Date:  2020-05       Impact factor: 3.500

Review 7.  Osseous Manifestations of Primary Hyperparathyroidism: Imaging Findings.

Authors:  Jackson Bennett; James W Suliburk; Fanny E Morón
Journal:  Int J Endocrinol       Date:  2020-02-21       Impact factor: 3.257

8.  Cured primary hyperparathyroidism after fine-needle aspiration biopsy-induced parathyroid disappearance.

Authors:  Elda Kara; Elisa Della Valle; Sara De Vincentis; Vincenzo Rochira; Bruno Madeo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-11-24

9.  Surgical Approach to Primary Hyperparathyroidism in Patients with Concomitant Thyroid Diseases: A Retrospective Single Center Study.

Authors:  Elena Castellano; Paolo Benso; Roberto Attanasio; Alberto Boriano; Corrado Lauro; Giorgio Borretta; Felice Borghi
Journal:  Int J Endocrinol       Date:  2020-02-22       Impact factor: 3.257

10.  A study on the causes of operative failures after microwave ablation for primary hyperparathyroidism.

Authors:  Wei Ying; Zhao Zhen-Long; Cao Xiao-Jing; Peng Li-Li; Li Yan; Yu Ming-An
Journal:  Eur Radiol       Date:  2021-03-02       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.